211 related articles for article (PubMed ID: 14507756)
21. Cell penetrating peptides as efficient nanocarriers for delivery of antifungal compound, natamycin for the treatment of fungal keratitis.
Jain A; Shah SG; Chugh A
Pharm Res; 2015 Jun; 32(6):1920-30. PubMed ID: 25467959
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of various types of imidazole derivatives for treatment of filamentous fungal keratitis].
Sun B; He Y; Wang Y
Zhonghua Yan Ke Za Zhi; 1996 Jul; 32(4):260-3. PubMed ID: 9590840
[TBL] [Abstract][Full Text] [Related]
23. Nanomicelles empower natamycin in treating fungal keratitis: An in vitro, ex vivo and in vivo study.
Sathe P; Kailasam V; Nagarjuna V; Sharma H; Velpandian T; Garg P; Nirmal J
Int J Pharm; 2024 May; 656():124118. PubMed ID: 38615806
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole.
Rose-Nussbaumer J; Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; Oldenburg CE; O'Brien KS; Ray KJ; Porco TC; McLeod SD; Acharya NR; Keenan JD; Lietman TM;
Br J Ophthalmol; 2016 Jul; 100(7):929-932. PubMed ID: 26531051
[TBL] [Abstract][Full Text] [Related]
25. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
Arora R; Gupta D; Goyal J; Kaur R
Clin Exp Ophthalmol; 2011 Jul; 39(5):434-40. PubMed ID: 21105974
[TBL] [Abstract][Full Text] [Related]
26. Fluconazole in filamentous fungal keratitis.
Rao SK; Madhavan HN; Rao G; Padmanabhan P
Cornea; 1997 Nov; 16(6):700. PubMed ID: 9395885
[No Abstract] [Full Text] [Related]
27. Fungal keratitis due to Schizophyllum commune: an emerging pathogenic fungus.
Reddy AK; Ashok R; Majety M; Chitta M; Narayen N
Mycoses; 2016 Dec; 59(12):757-759. PubMed ID: 27402206
[TBL] [Abstract][Full Text] [Related]
28. Colletotrichum keratitis.
Fernandez V; Dursun D; Miller D; Alfonso EC
Am J Ophthalmol; 2002 Sep; 134(3):435-8. PubMed ID: 12208257
[TBL] [Abstract][Full Text] [Related]
29. In vivo and in vitro investigations of fungal keratitis caused by Colletotrichum gloeosporioides.
Mitani A; Shiraishi A; Uno T; Miyamoto H; Hara Y; Yamaguchi M; Ohashi Y
J Ocul Pharmacol Ther; 2009 Dec; 25(6):563-5. PubMed ID: 20028265
[TBL] [Abstract][Full Text] [Related]
30. Bilateral fungal keratitis with ring infiltrates: a rare scenario.
Chaniyara MH; Pujari A; Urkude J; Sharma N
BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28993355
[TBL] [Abstract][Full Text] [Related]
31. Infectious keratitis caused by Aspergillus tubingensis.
Kredics L; Varga J; Kocsubé S; Rajaraman R; Raghavan A; Dóczi I; Bhaskar M; Németh TM; Antal Z; Venkatapathy N; Vágvölgyi C; Samson RA; Chockaiya M; Palanisamy M
Cornea; 2009 Sep; 28(8):951-4. PubMed ID: 19654512
[TBL] [Abstract][Full Text] [Related]
32. Reduced administration frequency for the treatment of fungal keratitis: a sustained natamycin release from a micellar solution.
Guo Y; Karimi F; Fu Q; G Qiao G; Zhang H
Expert Opin Drug Deliv; 2020 Mar; 17(3):407-421. PubMed ID: 32009483
[No Abstract] [Full Text] [Related]
33. Fungal keratitis caused by
Dudeja L; Jeganathan L; Prajna NV; Prajna L
Indian J Med Microbiol; 2018; 36(1):140-142. PubMed ID: 29735846
[TBL] [Abstract][Full Text] [Related]
34. Secondary pseudomonas infection of fungal keratitis following use of contaminated natamycin eye drops: a case series.
Krishnan T; Sengupta S; Reddy PR; Ravindran RD
Eye (Lond); 2009 Feb; 23(2):477-9. PubMed ID: 18820656
[TBL] [Abstract][Full Text] [Related]
35. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization.
Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH
Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672
[TBL] [Abstract][Full Text] [Related]
36. Curvularia keratitis.
Wilhelmus KR; Jones DB
Trans Am Ophthalmol Soc; 2001; 99():111-30; discussion 130-2. PubMed ID: 11797300
[TBL] [Abstract][Full Text] [Related]
37. Topical 5% Natamycin With Oral Ketoconazole in Filamentous Fungal Keratitis: A Randomized Controlled Trial.
Rajaraman R
Asia Pac J Ophthalmol (Phila); 2015; 4(6):399. PubMed ID: 26716437
[No Abstract] [Full Text] [Related]
38. Topical 5% Natamycin With Oral Ketoconazole in Filamentous Fungal Keratitis: A Randomized Controlled Trial.
Ravuri S; Mittal R; Bagga B
Asia Pac J Ophthalmol (Phila); 2015; 4(6):399. PubMed ID: 26716436
[No Abstract] [Full Text] [Related]
39. Determination of surgical outcomes with a novel formulation of intrastromal natamycin in recalcitrant fungal keratitis: A pilot study.
Saluja G; Sharma N; Agarwal R; Sharma HP; Maharana P; Satpathy G; Titiyal JS; Velpandian T
Indian J Ophthalmol; 2021 Oct; 69(10):2670-2674. PubMed ID: 34571612
[TBL] [Abstract][Full Text] [Related]
40. [Prolonged topical natamycin 5 % therapy before and after keratoplasty for Fusarium keratitis].
Cvetkova N; Köstler J; Prahs P; Helbig H; Dietrich-Ntoukas T
Ophthalmologe; 2016 May; 113(5):420-4. PubMed ID: 26205744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
